Technical brief: Access to TB testing and treatments: GeneXpert and delamanid

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Read More →

Survey: Core outcome set for Phase 3 studies of pulmonary TB treatment

An international survey seeks to determine the most important outcomes to measure in Phase 3 trials of pulmonary TB treatment.

Read More →

TB REACH Wave 11 now open for proposals

The TB REACH Wave 11 call for proposals is focused on innovative approaches to integrate TB service delivery with lung health at the primary and community level of the health systems.

Read More →

New guidance documents to support implementation of next generation sequencing to detect DR-TB

The World Health Organization issues two new guidance documents to support implementation of next generation sequencing to detect drug-resistant TB.

Read More →

TB Alliance launches five-country Phase 2 clinical trial evaluating next-generation TB drug

A combination of a new experimental compound, TBAJ-876, with pretomanid and linezolid, has the potential to become a 'universal TB regimen', shortening and improving treatment for both drug-sensitive and drug-resistant TB.

Read More →

New treatment safely prevents multidrug-resistant TB

Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults.

Read More →

Landmark clinical trial redefines multidrug-resistant TB treatment options

endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug–resistant TB.

Read More →

High cure rate with drug-resistant TB regimen

Results of LIFT-TB operational research on BPaL regimen for treating drug-resistant TB in Central and Southeast Asia.

Read More →

WHO launches new 5-year roadmap to prevent and treat TB in children and adolescents

The roadmap outlines an ambitious five-year plan with 10 key actions to improve the prevention, treatment, and care of TB in children and adolescents.

Read More →

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Read More →

Page 6 of 133 · Total posts: 10

←First 5 6 7 Last→